Keros Therapeutics, Inc. KROS

Set alert

Price alert · KROS

All alert types
11.04 USD -0.32 -2.82%

At close · Oct 30

11.04 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
10.98 × 2
Ask
11.05 × 2
10.98 Day range 11.49
9.91 52-week range 21.84
YTD
-45.78%
1 year
-26.55%
Open
11.36
Prev close
11.36
Mkt cap
218.89M
Vol
120.16K
Avg vol
189.16K
EPS
-3.22
P/E
0.00
Div yield
0.00%
More statistics
Low
10.98
High
11.49
Forward P/E
-3.00
Beta
1.24
Short ratio
5.28
Inst. own
100.86%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
55.00
200-d avg
53.85
1y target
43.55

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for KROS has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.72 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 5

Valuation

P/E 8.7×
FY 2018: -134×FY 2019: -14.4×FY 2020: -24.1×FY 2021: -23.2×FY 2022: -11.6×FY 2023: -7.6×FY 2024: -3.2×FY 2025: 8.7×
FY 2018 5y median -7.6× FY 2025
P/S 3.1×
FY 2018: 17.8×FY 2019: 17.8×FY 2020: 0.0×FY 2021: 67.9×FY 2022: 0.0×FY 2023: 7754×FY 2024: 167×FY 2025: 3.1×
FY 2018 5y median 67.9× FY 2025
P/B 2.5×
FY 2018: 14.0×FY 2019: 360×FY 2020: 4.2×FY 2021: 5.6×FY 2022: 4.4×FY 2023: 3.5×FY 2024: 1.0×FY 2025: 2.5×
FY 2018 5y median 3.5× FY 2025
P/FCF 7.2×
FY 2018: 26.1×FY 2019: -11.0×FY 2020: -29.4×FY 2021: -21.6×FY 2022: -17.0×FY 2023: -9.2×FY 2024: -3.6×FY 2025: 7.2×
FY 2018 5y median -9.2× FY 2025
EV/EBITDA 5.2×
FY 2018: -133×FY 2019: -14.5×FY 2020: -18.3×FY 2021: -20.2×FY 2022: -9.1×FY 2023: -5.6×FY 2024: -0.3×FY 2025: 5.2×
FY 2018 5y median -5.6× FY 2025
EV/Sales 2.0×
FY 2018: 15.6×FY 2019: 17.3×FY 2020: 0.0×FY 2021: 56.5×FY 2022: 0.0×FY 2023: 5656×FY 2024: 14.5×FY 2025: 2.0×
FY 2018 5y median 14.5× FY 2025
FCF Yield 14.0%
FY 2018: 3.8%FY 2019: -9.1%FY 2020: -3.4%FY 2021: -4.6%FY 2022: -5.9%FY 2023: -10.8%FY 2024: -27.5%FY 2025: 14.0%
FY 2018 5y median -5.9% FY 2025

Profitability

Gross Margin 99.4%
FY 2018: -1.1%FY 2019: -73.5%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 0.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 99.4%
FY 2018 5y median 100.0% FY 2025
Operating Margin 28.9%
FY 2018: -16.9%FY 2019: -105.6%FY 2020: 0.0%FY 2021: -280.5%FY 2022: 0.0%FY 2023: -112543.7%FY 2024: -5939.0%FY 2025: 28.9%
FY 2018 5y median -280.5% FY 2025
Net Margin 35.7%
FY 2018: -13.4%FY 2019: -123.4%FY 2020: 0.0%FY 2021: -292.3%FY 2022: 0.0%FY 2023: -101319.2%FY 2024: -5277.5%FY 2025: 35.7%
FY 2018 5y median -292.3% FY 2025
ROE 28.7%
FY 2018: -10.5%FY 2019: -2493.7%FY 2020: -17.3%FY 2021: -24.2%FY 2022: -37.7%FY 2023: -46.1%FY 2024: -32.8%FY 2025: 28.7%
FY 2018 5y median -32.8% FY 2025
ROIC 20.9%
FY 2018: -10.5%FY 2019: -154.3%FY 2020: -17.7%FY 2021: -23.1%FY 2022: -39.5%FY 2023: -49.0%FY 2024: -35.7%FY 2025: 20.9%
FY 2018 5y median -35.7% FY 2025
ROA 25.7%
FY 2018: -4.9%FY 2019: -112.7%FY 2020: -16.8%FY 2021: -23.0%FY 2022: -34.1%FY 2023: -41.3%FY 2024: -30.4%FY 2025: 25.7%
FY 2018 5y median -30.4% FY 2025

Growth (YoY)

Revenue 6775.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: -100.0%FY 2021: 0.0%FY 2022: -100.0%FY 2023: 0.0%FY 2024: 2251.0%FY 2025: 6775.0%
FY 2018 FY 2025
Operating Income 133.5%
FY 2018: 0.0%FY 2019: -524.7%FY 2020: -341.7%FY 2021: -20.8%FY 2022: -103.6%FY 2023: -48.0%FY 2024: -24.1%FY 2025: 133.5%
FY 2018 FY 2025
EPS (diluted) 146.0%
FY 2018: 0.0%FY 2019: -826.7%FY 2020: -110.8%FY 2021: 14.0%FY 2022: -64.7%FY 2023: -25.3%FY 2024: 3.8%FY 2025: 146.0%
FY 2018 FY 2025
Free Cash Flow 165.1%
FY 2018: 0.0%FY 2019: -338.4%FY 2020: -128.6%FY 2021: -69.9%FY 2022: -12.9%FY 2023: -78.1%FY 2024: -28.2%FY 2025: 165.1%
FY 2018 FY 2025

Financial Health

Current Ratio 15.5×
FY 2018: 2.2×FY 2019: 2.0×FY 2020: 37.3×FY 2021: 21.2×FY 2022: 17.3×FY 2023: 14.2×FY 2024: 21.5×FY 2025: 15.5×
FY 2018 5y median 17.3× FY 2025
Quick Ratio 15.5×
FY 2018: 2.2×FY 2019: 2.0×FY 2020: 37.3×FY 2021: 21.2×FY 2022: 17.3×FY 2023: 14.2×FY 2024: 21.5×FY 2025: 15.5×
FY 2018 5y median 17.3× FY 2025
Debt / Equity 0.1×
FY 2018: 0.1×FY 2019: 2.6×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA -2.9×
FY 2018: 19.2×FY 2019: 0.5×FY 2020: 5.9×FY 2021: 4.1×FY 2022: 2.6×FY 2023: 2.1×FY 2024: 2.9×FY 2025: -2.9×
FY 2018 5y median 2.6× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: -1320×FY 2020: -7776×FY 2021: -14093×FY 2022: -114790×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31